- Home
- APGE vs LAZ Comparison
APGE vs LAZ Comparison
Compare APGE & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APGE | LAZ |
|---|---|---|
| Founded | 2022 | 1848 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.7B |
| IPO Year | 2023 | 2005 |
Fundamental Metrics
Financial Performance| Metric | APGE | LAZ |
|---|---|---|
| Price | $73.56 | $48.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | ★ $99.44 | $55.38 |
| AVG Volume (30 Days) | ★ 970.7K | 951.3K |
| Earning Date | 11-10-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.52 |
| Revenue | N/A | ★ $3,016,853,000.00 |
| Revenue This Year | N/A | $0.62 |
| Revenue Next Year | N/A | $17.34 |
| P/E Ratio | ★ N/A | $19.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.20 | $31.97 |
| 52 Week High | $80.99 | $58.07 |
Technical Indicators
Market Signals| Indicator | APGE | LAZ |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 41.11 |
| Support Level | $74.89 | $48.83 |
| Resistance Level | $78.34 | $50.29 |
| Average True Range (ATR) | 2.82 | 1.23 |
| MACD | -0.95 | -0.24 |
| Stochastic Oscillator | 13.97 | 5.92 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About LAZ Lazard Inc.
Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.